You J, Lee C, Lee Y, Chern Y, Liao C, Hsu H
Transl Oncol. 2024; 52():102198.
PMID: 39657310
PMC: 11683267.
DOI: 10.1016/j.tranon.2024.102198.
Siwicki R, Shore J, Norman R
Cureus. 2024; 16(4):e59349.
PMID: 38817459
PMC: 11137641.
DOI: 10.7759/cureus.59349.
Jeong B, Pahan K
Immuno. 2024; 4(1):77-90.
PMID: 38435456
PMC: 10907066.
DOI: 10.3390/immuno4010005.
Jana M, Prieto S, Gorai S, Dasarathy S, Kundu M, Pahan K
J Neurochem. 2024; 168(7):1340-1358.
PMID: 38419348
PMC: 11260247.
DOI: 10.1111/jnc.16084.
Sheinin M, Mondal S, Pahan K
Cancers (Basel). 2023; 15(24).
PMID: 38136341
PMC: 10742282.
DOI: 10.3390/cancers15245796.
Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathways.
Ciummo S, Sorrentino C, Fieni C, Di Carlo E
J Exp Clin Cancer Res. 2023; 42(1):336.
PMID: 38087324
PMC: 10714661.
DOI: 10.1186/s13046-023-02902-y.
Induction of IL-2 by interleukin-12 p40 homodimer and IL-12, but not IL-23, in microglia and macrophages: Implications for multiple sclerosis.
Jana M, Mondal S, Jana A, Pahan K
Cytokine. 2023; 174:156457.
PMID: 38056248
PMC: 10872483.
DOI: 10.1016/j.cyto.2023.156457.
Immune mediators as predictive biomarkers for anti-PD-1 antibody therapy in urothelial carcinoma.
Shibata Y, Kishida T, Kouro T, Wei F, Igarashi Y, Himuro H
Front Pharmacol. 2023; 14:1269935.
PMID: 38026978
PMC: 10679331.
DOI: 10.3389/fphar.2023.1269935.
Crohn's disease and breast cancer: a literature review of the mechanisms and treatment.
Zhou S, Yu J
Intern Emerg Med. 2023; 18(5):1303-1316.
PMID: 37138170
PMC: 10412481.
DOI: 10.1007/s11739-023-03281-0.
A Multigene-Panel Study Identifies Single Nucleotide Polymorphisms Associated with Prostate Cancer Risk.
Manca M, Scarpa F, Cossu D, Simula E, Sanna D, Ruberto S
Int J Mol Sci. 2023; 24(8).
PMID: 37108754
PMC: 10142258.
DOI: 10.3390/ijms24087594.
Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment.
Habanjar O, Bingula R, Decombat C, Diab-Assaf M, Caldefie-Chezet F, Delort L
Int J Mol Sci. 2023; 24(4).
PMID: 36835413
PMC: 9964711.
DOI: 10.3390/ijms24044002.
Regression of Lung Cancer in Mice by Intranasal Administration of SARS-CoV-2 Spike S1.
Sheinin M, Jeong B, Paidi R, Pahan K
Cancers (Basel). 2022; 14(22).
PMID: 36428739
PMC: 9688283.
DOI: 10.3390/cancers14225648.
: a novel immune prognostic biomarker for oral squamous cell carcinoma and linked to expression in the tumor immune microenvironment.
Chen Z, Chen Q, Li S, Tu S, Chen Q, Wang A
Ann Transl Med. 2022; 10(3):144.
PMID: 35284546
PMC: 8904997.
DOI: 10.21037/atm-21-6915.
Regression of Triple-Negative Breast Cancer in a Patient-Derived Xenograft Mouse Model by Monoclonal Antibodies against IL-12 p40 Monomer.
Kundu M, Raha S, Roy A, Pahan K
Cells. 2022; 11(2).
PMID: 35053375
PMC: 8773899.
DOI: 10.3390/cells11020259.
A Double-Edged Sword Role of Cytokines in Prostate Cancer Immunotherapy.
Mao C, Ding Y, Xu N
Front Oncol. 2021; 11:688489.
PMID: 34868907
PMC: 8635015.
DOI: 10.3389/fonc.2021.688489.
High IL-23+ cells infiltration correlates with worse clinical outcomes and abiraterone effectiveness in patients with prostate cancer.
Liu Z, Zhang J, Yang Y, Chang K, Wang Q, Kong Y
Asian J Androl. 2021; 24(2):147-153.
PMID: 34755700
PMC: 8887101.
DOI: 10.4103/aja202173.
Activation of PPARα enhances astroglial uptake and degradation of β-amyloid.
Raha S, Ghosh A, Dutta D, Patel D, Pahan K
Sci Signal. 2021; 14(706):eabg4747.
PMID: 34699252
PMC: 8793854.
DOI: 10.1126/scisignal.abg4747.
Overcoming Immune Resistance in Prostate Cancer: Challenges and Advances.
Movassaghi M, Chung R, Anderson C, Stein M, Saenger Y, Faiena I
Cancers (Basel). 2021; 13(19).
PMID: 34638243
PMC: 8507531.
DOI: 10.3390/cancers13194757.
Psychosocial Stress and Age Influence Depression and Anxiety-Related Behavior, Drive Tumor Inflammatory Cytokines and Accelerate Prostate Cancer Growth in Mice.
Bellinger D, Dulcich M, Molinaro C, Gifford P, Lorton D, Gridley D
Front Oncol. 2021; 11:703848.
PMID: 34604038
PMC: 8481826.
DOI: 10.3389/fonc.2021.703848.
Immunology of IL-12: An update on functional activities and implications for disease.
Ullrich K, Schulze L, Paap E, Muller T, Neurath M, Zundler S
EXCLI J. 2021; 19:1563-1589.
PMID: 33408595
PMC: 7783470.
DOI: 10.17179/excli2020-3104.